Ramona Doyle
Vorstandsvorsitzender bei The MAVEN Project
Aktive Positionen von Ramona Doyle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The MAVEN Project | Vorstandsvorsitzender | 01.09.2020 | - |
The University of California, San Francisco | Corporate Officer/Principal | 01.10.2011 | - |
Karriereverlauf von Ramona Doyle
Ehemalige bekannte Positionen von Ramona Doyle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 | 07.06.2022 |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 01.05.2018 |
California Institute for Regenerative Medicine | Corporate Officer/Principal | 01.07.2015 | 01.07.2016 |
Stanford University School of Medicine | Corporate Officer/Principal | 01.01.1995 | 01.01.2008 |
Ausbildung von Ramona Doyle
University of Oxford | Graduate Degree |
Sewanee-The University of the South | Undergraduate Degree |
Emory University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 2 |
Sektoral
Consumer Services | 6 |
Health Technology | 2 |
Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RECURSION PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
California Institute for Regenerative Medicine | Government |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Commercial Services |
The MAVEN Project |
- Börse
- Insiders
- Ramona Doyle
- Erfahrung